The Drug Regulatory Authority of Pakistan (DRAP) has issued new advisories urging pharmaceutical manufacturers to adopt Multiple Sourcing Strategies for raw materials. By diversifying our supply chains, the industry is building the resilience needed to navigate global logistical challenges and ensure that essential medicines remain available to the public without interruption.
PPMA remains committed to supporting these initiatives for a more secure and stable healthcare ecosystem.
